One of the most common early signs of prostate cancer is trouble with urination. Urination is affected because the prostate ...

A new preclinical study unveils a more powerful and effective immunotherapy for bladder cancer and other solid tumours.

A new study found that small, daily interventions which helped men cope with the physical and mental distress of prostate ...

TYRA-300 is the only orally administered investigational agent in clinical development for IR NMIBC- -Initial 3-month complete response (CR) data expected to be reported ...

Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) ("Lipella" or the "Company"), a clinical-stage biotechnology company focused on developing therapies for diseases ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.